Author:
Shulman Matisyahu,Provost Scott,Ohrtman Kaitlyn,Novo Patricia,Meyers-Ohki Sarah,Van Veldhuisen Paul,Oden Neal,Otterstatter Michael,Bailey Genie L.,Liu David,Rotrosen John,Nunes Edward V.,Weiss Roger D.
Funder
National Institute on Drug Abuse
NIDA CTN
Reference43 articles.
1. Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine;Mendelson;Exp. Clin. Psychopharmacol.,2008
2. A multi-site, two-phase, prescription opioid addiction treatment study (POATS): rationale, design, and methodology;Weiss;Contemp. Clin. Trials,2010
3. Medicine NA of S Engineering, and, Division H and M, Policy B on HS, Disorder C on MAT for OU. Medications for Opioid Use Disorder Save Lives,2019
4. Effectiveness of treatment for opioid use disorder: a national, five-year, prospective, observational study in England;Eastwood;Drug Alcohol Depend.,2017
5. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial;Hser;Addiction,2016